2298 articles by Nick Paul Taylor
-
Medtronic, Tempus testing AI to find potential TAVR patients
Nov. 25, 2024 -
Medtronic buys surgical instrument developer Fortimedix
Nov. 22, 2024 -
Dexcom invests $75M in ÅŒura, agrees to integrate smart rings and CGMs
Nov. 20, 2024 -
Abbott opens plant in Ireland to boost Libre 3 sensor production
Nov. 19, 2024 -
FDA warns providers on Getinge devices tied to 17 serious injuries
Nov. 18, 2024 -
Thermo Fisher eliminating 160 jobs, closing Massachusetts facility
Nov. 15, 2024 -
FDA breakthrough device decisions rebound after recent declines
Nov. 14, 2024 -
GE Healthcare’s head-only MRI scanner cleared by the FDA
Nov. 14, 2024 -
Livanova hits sleep apnea trial goals, plans FDA filing
Nov. 13, 2024 -
GE Healthcare inks AI mammography pact with Radnet
Nov. 12, 2024 -
Exact Sciences’ forecast cut shocks analysts
Nov. 8, 2024 -
Inquis raises $40M for pivotal trial of clot removal device
Nov. 7, 2024 -
Siemens Healthineers confident it can cope with Trump tariffs
Nov. 7, 2024 -
Advamed asks CMS to cover extra imaging of dense breast tissue
Nov. 6, 2024 -
Integra Lifesciences names Mojdeh Poul as CEO
Nov. 5, 2024 -
Zimmer licenses NeuroOne brain ablation system
Nov. 4, 2024 -
EU posts guidance on ethylene oxide in device sterilization
Nov. 1, 2024 -
Edwards, Medtronic and Inari share trial data at TCT conference
Oct. 31, 2024 -
Exactech files for Chapter 11, agrees to investor buyout
Oct. 30, 2024 -
J&J to seek FDA approval after small-bore Impella heart pump hits trial goal
Oct. 29, 2024 -
Philips cuts sales forecast after ‘significant deterioration’ in China
Oct. 28, 2024 -
Medtronic wins FDA approval for Affera mapping and ablation system
Oct. 25, 2024 -
European Parliament calls for proposals to reform MDR and IVDR by end of Q1
Oct. 24, 2024 -
Hologic to lay off 86 people in closure of Connecticut facility
Oct. 23, 2024 -
Boston Scientific, Edwards and Dexcom usher in second week of earnings
Oct. 22, 2024